Cardioprotective effects of alpha‐mangostin on doxorubicin‐induced cardiotoxicity in rats
Authors:
- Farhad EisvandFEFarhad Eisvand
- Mohsen ImenshahidiMIMohsen Imenshahidi
- Mahboobeh Ghasemzadeh RahbardarMRMahboobeh Ghasemzadeh Rahbardar
- Seyed Abbas Tabatabaei YazdiSYSeyed Abbas Tabatabaei Yazdi
- Maryam RameshradMRMaryam Rameshrad
- Bibi Marjan RazaviBRBibi Marjan Razavi
- Hossein HosseinzadehHHHossein Hosseinzadeh
- 27 December 2021
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 36 (1) , 506-524
Abstract
The main adverse effect of doxorubicin is cardiotoxicity. Oxidative stress and apoptosis induction have been suggested as mechanisms involved in its cardiotoxicity. In this study, cardioprotective effects of alpha‐mangostin against doxorubicin‐induced cardiotoxicity have been investigated in rats. Forty‐two rats were divided as follows: Control, doxorubicin (2 mg/kg every 48 hr), alpha‐mangostin (200 mg/kg), alpha‐mangostin (50, 100, 200 mg/kg) + doxorubicin (2 mg/kg every 48 hr), and vitamin E (200 IU/kg) + doxorubicin (2 mg/kg every 48 hr). Alpha‐mangostin was administered by gavage for 19 days, while doxorubicin (12 days) and vitamin E (19 days) were injected intraperitoneally. Doxorubicin decreased heart rate, increased electrocardiogram signal components duration and reduced systolic and diastolic arterial blood pressure, and caused histological damage in the heart of rats. Doxorubicin decreased heart weight and heart/body weight ratio, as well as elevated creatine phosphokinase isoenzyme and lactate dehydrogenase. Doxorubicin increased malondialdehyde, inflammatory biomarkers, and caspases 3 and 9 and decreased reduced glutathione content in heart tissue but co‐administration of alpha‐mangostin (100 mg/kg) restored all doxorubicin toxic effects. Results show that alpha‐mangostin has protective effects against doxorubicin‐induced cardiotoxicity by antioxidant, antiinflammatory, and antiapoptotic effects that may ameliorate doxorubicin cardiotoxicity in human chemotherapy without reduction in its anticancer effect.Keywords
This publication has 83 references indexed in Scilit:
- Effects of alpha-mangostin on the expression of anti-inflammatory genes in U937 cellsChinese Medicine, 2012
- Cardioprotective effect of methanolic extract of Ixora coccinea Linn. leaves on doxorubicin-induced cardiac toxicity in ratsIndian Journal of Pharmacology, 2012
- Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cellsToxicology, 2010
- Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAILMolecular Cancer, 2010
- Doxorubicin CardiomyopathyCardiology, 2009
- Cardiomyocyte death in doxorubicin-induced cardiotoxicityArchivum Immunologiae et Therapiae Experimentalis, 2009
- The NF- B Family of Transcription Factors and Its RegulationCold Spring Harbor Perspectives in Biology, 2009
- Ameliorative prospective of alpha-mangostin, a xanthone derivative from Garcinia mangostana against β-adrenergic cathecolamine-induced myocardial toxicity and anomalous cardiac TNF-α and COX-2 expressions in ratsExperimental and Toxicologic Pathology, 2008
- Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liverBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Ueber das MangostinEuropean Journal of Organic Chemistry, 1855